Direct Medical Costs of Advanced Breast Cancer Treatment:A Real-World Study in the Southeast of The Netherlands

OBJECTIVES: Policy makers increasingly seek to complement data from clinical trials with information from routine care. This study aims to provide a detailed account of the hospital resource use and associated costs of patients with advanced breast cancer in The Netherlands. METHODS: Data from 597 patients with advanced breast cancer, diagnosed between 2010 and 2014, were retrieved from the Southeast Netherlands Advanced Breast Cancer Registry. Database lock for this study was in October 2017. We report the observed hospital costs for different resource categories and the lifetime costs per pa... Mehr ...

Verfasser: Schneider, Paul Peter
Ramaekers, Bram L
Pouwels, Xavier
Geurts, Sandra
Ibragimova, Khava
de Boer, Maaike
Vriens, Birgit
van de Wouw, Yes
den Boer, Marien
Pepels, Manon
Tjan-Heijnen, Vivianne
Joore, Manuela
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Schneider , P P , Ramaekers , B L , Pouwels , X , Geurts , S , Ibragimova , K , de Boer , M , Vriens , B , van de Wouw , Y , den Boer , M , Pepels , M , Tjan-Heijnen , V & Joore , M 2021 , ' Direct Medical Costs of Advanced Breast Cancer Treatment : A Real-World Study in the Southeast of The Netherlands ' , Value in Health , vol. 24 , no. 5 , pp. 668-675 . https://doi.org/10.1016/j.jval.2020.12.007
Schlagwörter: BEVACIZUMAB / CARE / ECONOMIC BURDEN / SURVIVAL / The Netherlands / WOMEN / breast neoplasms / healthcare costs / healthcare utilization / real-world data
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26822149
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/d991a017-ad8e-4c80-8fda-edd767ae67c6